closedosingdownloadefficacymoasafetytable-checktable-cross

The OTEZLA® international website

This site is intended for healthcare professionals outside the U.S.

CONSIDER ORAL OTEZLA FOR YOUR PSORIASIS PATIENTS

Oral psoriasis treatment options1
 
OTEZLA
Skilarence®
Methotrexate
Acitretin
Cyclosporine
Treatment considerations
Indicated for PsO and PsA
Titration period5 daysUp to 9 weeksUp to 8 weeks
No label-required laboratory prescreening or ongoing monitoring
Warnings and precautions
  • -Diarrhea
  • -Nausea
  • -Vomiting
  • -Depression
  • -Severe renal impairment
  • -Pregnancy
  • -Weight Loss
  • -Decreased blood cell counts
  • -Opportunistic infections/PML
  • -Severe gastrointestinal disorders
  • -Severe hepatic or renal impairment
  • -Fanconi syndrome
  • -Pregnancy or nursing
  • -Liver function abnormalities
  • -Alcohol use
  • -Active infectious disease
  • -Immunosuppression
  • -Diabetes mellitus
  • -Pregnancy
  • -Significant hematologic abnormalities
  • -Pregnancy category X*
  • -Severe liver failure
  • -Severe kidney failure
  • -Alcohol use
  • -Lymphomas
  • -Skin malignancy
  • -Infections (including opportunistic)
  • -Renal toxicity
  • -Hepatoxicity
  • -Hypertension
  • -Hyperkaelemia
  • -Neurotoxicity
  • -Pregnancy
  • -Alcohol use

aPregnancy category X (contraception starting 1 month before treatment and 2-year wait period after cessation to become pregnant).

Reference:

  1. Data on file, Celgene Corporation.
You are leaving the OTEZLA® (apremilast) website
Do you wish to leave this site?
OTEZLA International Websites
OTEZLA is approved in 51 Countries
  • United States

  • Canada

  • Australia

  • Israel

  • Switzerland

  • New Zealand

  • Austria

  • Belgium

  • Bulgaria

  • Croatia

  • Republic of Cyprus

  • Czech Republic

  • Denmark

  • Estonia

  • Finland

  • France

  • Germany

  • Greece

  • Hungary

  • Ireland

  • Italy

  • Latvia

  • Lithuania

  • Luxembourg

  • Malta

  • Netherlands

  • Poland

  • Portugal

  • Romania

  • Slovakia

  • Slovenia

  • Spain

  • Sweden

  • United Kingdom

  • Norway

  • Iceland

  • Liechtenstein

  • Russia

  • Japan

  • Hong Kong

  • Singapore

  • Kuwait

  • Taiwan

  • UAE

  • Korea

  • Thailand

  • Lebanon

  • Qatar

  • Argentina

  • Mexico

  • Brazil